Response of obstetric patients with ITP to treatment
Treatment . | Total no. pregnancies . | No. in CR . | No. in PR . | No. with NR . | No. with insufficient data to document response . |
---|---|---|---|---|---|
No treatment | 82 | NA | NA | NA | NA |
All treatments | 37 | 6 | 11 | 9 | 11 |
Corticosteroids | 8 | 1 | 2 | 1 | 4 |
IV IgG | 20 | 4 | 7 | 5 | 4 |
Corticosteroids and IV IgG | 7 | 1 | 1 | 3 | 2 |
Corticosteroids, IV IgG, and anti-D | 1 | 0 | 0 | 0 | 1 |
Corticosteroids and anti-D | 1 | 0 | 1 | 0 | 0 |
Treatment . | Total no. pregnancies . | No. in CR . | No. in PR . | No. with NR . | No. with insufficient data to document response . |
---|---|---|---|---|---|
No treatment | 82 | NA | NA | NA | NA |
All treatments | 37 | 6 | 11 | 9 | 11 |
Corticosteroids | 8 | 1 | 2 | 1 | 4 |
IV IgG | 20 | 4 | 7 | 5 | 4 |
Corticosteroids and IV IgG | 7 | 1 | 1 | 3 | 2 |
Corticosteroids, IV IgG, and anti-D | 1 | 0 | 0 | 0 | 1 |
Corticosteroids and anti-D | 1 | 0 | 1 | 0 | 0 |
Patients were considered to have complete response (CR) if their platelet counts increased to more than 150 × 109/L during or after therapy. Patients were considered to have partial response (PR) if their platelet counts increased to 50 × 109/L or higher but lower than 150 × 109/L at, during, or after therapy. Patients were considered to have no response (NR) if the platelet count remained lower than 50 × 109/L during or after therapy.
NA indicates not applicable.